Validating the Speckle Tracking Methods on Soft Tissue Strain, Displacement, and Roles in Physical Therapy

March 16, 2026 updated by: National Taiwan University Hospital

Validating the Speckle Tracking Methods on Soft Tissue Strain, Displacement, and Roles in Physical Therapy: Ligaments (Sports), Tendons (Dysfunction), and Muscles (Exercise Intervention)

This three-year research project aims to test the hypothesis that strain and displacement characteristics of human soft tissues are influenced by (1) habitual physical activity, (2) functional impairment, and (3) training interventions. Over the three years, the ulnar collateral ligament of the elbow, the ankle tendon, and the hamstring muscles will be investigated sequentially. Ultrasound speckle-tracking techniques will be employed to verify these hypotheses and to provide a basis for clinical risk assessment of injury, development of therapeutic strategies, and evaluation of rehabilitation outcomes.

In the first year, strain and displacement of the medial ulnar collateral ligament (MUCL) in both longitudinal and transverse directions during passive isokinetic elbow valgus loading will be analyzed in baseball pitchers at high and low injury risk and in healthy controls. The results will be compared with ultrasonic shear-wave elastography. Participants will then undergo an 8-week low- to moderate-intensity blood-flow restriction resistance training program. This phase is expected to characterize ligament mechanical adaptations to long-term sports training, elucidate the relationship between such adaptations and injury risk, and evaluate the effects of resistance training on enhancing medial elbow joint stability.

In the second year, individuals with posterior tibial tendon dysfunction and healthy controls will be examined. Longitudinal strain and displacement, as well as transverse rotation and displacement of the tibialis posterior tendon during active ankle movements will be quantified and compared with shear-wave elastography measurements. These results are expected to clarify the relationship between tendon strain-displacement behavior and tendon dysfunction, provide mechanistic insights into tendon pathology, and inform optimal therapeutic strategies.

In the third year, patients following anterior cruciate ligament (ACL) reconstruction will be investigated. Longitudinal strain and displacement of the hamstring graft donor site, specifically the semitendinosus muscle-tendon unit, following eccentric training will be assessed and compared with shear-wave elastography and electromyography. This phase is expected to characterize post-harvest semitendinosus muscle activity patterns and their associations with postoperative muscle strength deficits.

By integrating findings across the three phases, the anticipated clinical implications of this project include determining whether:

  1. adaptive responses of ligaments to repetitive tensile loading during long-term sports participation (including strain behavior and mechanical properties) can serve as screening indicators for injury risk, and evaluating the effects of blood-flow restriction resistance training in these populations;
  2. three-dimensional strain, displacement, and rotation of tendons in response to muscle contraction and joint motion are associated with tendon dysfunction; and
  3. strain and displacement characteristics of the semitendinosus muscle (in relation to muscle recruitment) can be improved through postoperative functional training following its use as a graft source.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Taipei, Taiwan, 100025
        • Recruiting
        • School and Graduate Institute of Physical Therapy, College of Medicine, National Taiwan University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Study 1

  • male pitchers aged between 18 and 35 years
  • more than five years of pitching experience
  • at least 200 counts of pitching training per week

Study 2

  • Age between 20 and 65 years
  • diagnosed with grade II posterior tibial tendon dysfunction and recommended by a physician for surgical intervention

Study 3

  • The participants were between 18 and 45 years old
  • had undergone unilateral anterior cruciate ligament semitendinosus tendon autograft reconstruction surgery within the past 6 years
  • were able to fully participate in the sports and training they had before their injury

Exclusion Criteria:

Study 1

  • diagnosed with partial or full thickness tears of the UCL by arthrographic/ nonarthrographic MR techniques in past medical records
  • having a positive result in the "moving valgus stress test" screening24
  • unable to participate in regular baseball pitching training or absent from the competition during the March 2023 to March 2025 season
  • found to show suspicious signs, such as hypoechoic foci and calcification, which suggest UCL injury under ultrasound screening4
  • with a <80% compliance rate in the eight-week BFRT

Study 2

  • The lower extremities have undergone surgical intervention
  • The lower extremities have a known history of nerve or vascular injury
  • The ankles and feet have known ligament tears
  • Fixed deformities of the foot joints
  • The patient has a known physical condition that would affect the conduct of the experiment

Study 3

  • Having any orthopedic condition that prevents them from participating in the competition, such as arthritis or knee pain
  • having a history of hamstring muscle strain in the knee within the past 3 months
  • having an attendance rate of less than 80% in the subsequent eight weeks of training

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Study 1: male collegiate baseball pitchers; Study 3: ACLR patient
Study 1: Male collegiate baseball pitchers receiving 8 weeks of blood flow restriction training of their forearm flexor-pronator muscles Study 3: ACLR patient receiving 8 weeks of Nordic exercise training
The investigators anticipate providing blood flow restriction training to the forearm flexor-pronator muscles of male collegiate baseball pitchers in study 1.
The investigators anticipate providing Nordic hamstring exercise training to ACLR patients in study 3.
No Intervention: Study 1: male collegiate baseball pitchers ; Study 2: TP dysfunction patient; Study 3: ACLR patient
Study 1: healthy male collegiate baseball pitchers control group; Study 2: TP dysfunction patient; Study 3: ACLR patient

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Study 1: regional strain
Time Frame: From enrollment to the end of treatment at 8 weeks
Regional strain of the ulnar collateral ligament conducted by ultrasound speckle tracking
From enrollment to the end of treatment at 8 weeks
Study 3: tendon displacement
Time Frame: Day 1
Tendon displacement of the semitendinosus tendon was assessed using ultrasound speckle tracking
Day 1
Study 2: tendon torsion
Time Frame: Day 1
Tendon torsion of the tibialis posterior was conducted by the speckle tracking analysis
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Study 1: shear wave speed
Time Frame: From enrollment to the end of treatment at 8 weeks
Shear wave speed of the ulnar collateral ligament conducted by shear wave elastography
From enrollment to the end of treatment at 8 weeks
Study 3: shear wave speed
Time Frame: Day 1
Shear wave speed of the semitendinosus tendon conducted by shear wave elastography
Day 1
Study 2: shear wave speed
Time Frame: Day 1
Shear wave speed of the tibialis posterior tendon conducted by hear wave elastography
Day 1
Study 1: muscle strength
Time Frame: From enrollment to the end of treatment at 8 weeks
Muscle strength of the flexor-pronator muscles conducted by dynamometer
From enrollment to the end of treatment at 8 weeks
Study 3: muscle strength
Time Frame: Day 1
Muscle strength of the semitendinosus muscle conducted by the dynamometer
Day 1
Stusy 2: muscle strength
Time Frame: Day 1
Muscle strength of the tibialis posterior muscle conducted by the dynamometer
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

March 9, 2026

First Submitted That Met QC Criteria

March 16, 2026

First Posted (Actual)

March 20, 2026

Study Record Updates

Last Update Posted (Actual)

March 20, 2026

Last Update Submitted That Met QC Criteria

March 16, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tibialis Posterior Dysfunction

Clinical Trials on blood flow restriction training

Subscribe